SIGNIFICANTLY REDUCING ITCHING AND IMPROVING QUALITY OF LIFE: ATODERM SOS SPRAY CLINICAL STUDY ON 120 PATIENTS 5-D SCALE : RESULTS ON 4 SKIN CONDITIONS Laboratoire Bioderma conducted a clinical trial on 120 patients suffering from pruritus due to one of the...
More
SIGNIFICANTLY REDUCING ITCHING AND IMPROVING QUALITY OF LIFE: ATODERM SOS SPRAY CLINICAL STUDY ON 120 PATIENTS 5-D SCALE : RESULTS ON 4 SKIN CONDITIONS Laboratoire Bioderma conducted a clinical trial on 120 patients suffering from pruritus due to one of the 4 targeted indications of Atoderm SOS Spray: Atopic Dermatitis, Psoriasis, Chronic idiopathic urticaria and Senile xerosis. This 21 day clinical study had an objective to evaluate the efficacy on the itching, patients’ quality of life and their skin condition. Figure 1: Clinical efficacy in AD (5D Figure 2: Clinical efficacy in itching scale) psoriasis (5D itching scale) Overall efficacy on itching After 21 days, we have observed that Atoderm SOS Spray reduced significantly the score of itching [5-D scale tool], respectively, on Atopic Dermatitis -51% (Fig. 1); on Psoriasis -36% (Fig. 2); on Senile xerosis - 36% (Fig. 3) and on Chronic idiopathic urticaria -35% (Fig. 4). Figure 3: Clinical efficacy in Figure 4: Clinical efficacy in
Less
